Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Multicentre, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy, Safety and Tolerability of Three Dose Regimens of Topical Nitric Oxide in Patients With Anogenital Warts

NCT02015260 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.

NCT NCT02015260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02015260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Multicentre, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy, Safety and Tolerability of Three Dose Regimens of Topical Nitric Oxide in Patients With Anogenital Warts
Lead sponsor
University of Aberdeen
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
May 31, 2003
Enrollment
299 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anogenital warts, condylomata acuminata